Clinical geneticists and industry experts have raised concerns that GeneDx's tests do not offer superior accuracy compared to competitors, and the company lacks any sustainable competitive ...

We recently published a list of 12 High Growth Low Debt Stocks to Invest in Now. In this article, we are going to take a look ...

GeneDx recognized for its innovative approach ... and challengers that are introducing bold ideas and vital competition to their industries. At a time when the world is rapidly shifting, these ...

Reports FY24 revenue $305.5M, consensus $290.82M .”The fourth quarter capped an outstanding year for GeneDx (WGS), as we work to end the diagnostic odyssey with earlier intervention using our ...

GeneDx Holdings Corp. (NASDAQ ... growing data asset and clinical expertise differentiate our products from competitors by enabling us to identify novel gene disease connections that are not ...

GAITHERSBURG, Md., March 13, 2025--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, announced today its scientific contributions ...

GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced Multiscore, an advanced AI-powered decision ...

GAITHERSBURG, Md., March 04, 2025--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, announced today an indication expansion for its ...